2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
John P. Leonard, MD, medical oncology, Weill Cornell Medicine and New-York Presbyterian, discusses treatment considerations for relapsed patients with follicular lymphoma.
John P. Leonard, MD, medical oncology, Weill Cornell Medicine and New-York Presbyterian, discusses treatment considerations for relapsed patients with follicular lymphoma.
Approximately 80% of patients with follicular lymphoma will likely not die from their disease, but with their disease, Leonard explains. Several ongoing studies show that early treatment does not necessarily improve long-term outcomes.
Factors that influence treatment choices include bulk of disease, symptoms, and asymptomatic progression, Leonard adds.
Related Content: